1999
DOI: 10.1128/cdli.6.2.168-172.1999
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Western Blot Assay for Detection of Bovine Immunodeficiency-Like Virus Using Capsid and Transmembrane Envelope Proteins Expressed from Recombinant Baculovirus

Abstract: A 120-amino-acid polypeptide selected from the transmembrane protein region (tTM) and the major capsid protein p26 of bovine immunodeficiency-like virus (BIV) were expressed as fusion proteins from recombinant baculoviruses. The antigenic reactivity of both recombinant fusion proteins was confirmed by Western blot with bovine and rabbit antisera to BIV. BIV-negative bovine sera and animal sera positive for bovine syncytial virus and bovine leukemia virus failed to recognize the recombinant fusion proteins, the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0
2

Year Published

2004
2004
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 40 publications
1
4
0
2
Order By: Relevance
“…In contrast, immune reactivity to the envelope TM protein of BIV, which appears later in the course of BIV infection, was still detectable at the end of the experiment period (up to 3.5 or 4 years after infection). These results are in accordance with our own data, in which immune reactivity to the BIV TM was detected in cattle whose sera failed to recognize the p26 protein (Abed et al, 1999;Abed and Archambault, 2000). Whether these changes in antibody production reflect differences in the apparently differential expression of the gag and env gene products in vivo late in infection is at present unknown.…”
Section: The Biv Gag Pol and Env Gene-encoded Productssupporting
confidence: 92%
See 2 more Smart Citations
“…In contrast, immune reactivity to the envelope TM protein of BIV, which appears later in the course of BIV infection, was still detectable at the end of the experiment period (up to 3.5 or 4 years after infection). These results are in accordance with our own data, in which immune reactivity to the BIV TM was detected in cattle whose sera failed to recognize the p26 protein (Abed et al, 1999;Abed and Archambault, 2000). Whether these changes in antibody production reflect differences in the apparently differential expression of the gag and env gene products in vivo late in infection is at present unknown.…”
Section: The Biv Gag Pol and Env Gene-encoded Productssupporting
confidence: 92%
“…In these infected rabbits, BIV was rescued from PBMC and spleen, lymph nodes and brain by the cocultivation method (Pifat et al, 1992). Moreover, a rapid and long-lasting virus-specific humoral immune response was observed in rabbits infected with BIV (Abed et al, 1999;Abed and Archambault, 2000). No clinical symptoms were observed in BIV-infected animals during all these studies.…”
Section: Transmission Cell Tropism and Host Range Of Bivmentioning
confidence: 96%
See 1 more Smart Citation
“…Calves experimentally infected with BIV R-29 isolates displayed intermittent lymphocytosis and lymphadenopathy without any obvious clinical indications (Carpenter et al 1992 ; Onuma et al 1992 ; Suarez et al 1993 ). Virus-specific antibodies found in calves against BIV R-29 strain (Whetstone et al 1990 ) were primarily to p26, which is the most immunodominant protein of BIV (Abed et al 1999 ). Also, cattle infected with BLV produced antibodies that can inhibit HIV-1 reverse transcriptase activity in vitro (Gillet et al 2007 ).…”
Section: Introductionmentioning
confidence: 99%
“…Capsid antigens are often used in these assays since antibodies to this protein develop first and are usually highly conserved within each lentiviral group (Burki et al, 1992;Houwers and Nauta, 1989;Zanoni et al, 1991). Recombinant CA and truncated transmembrane (TM) proteins have been used for the detection of BIV infections using Western blot assays (Abed et al, 1999). An immunodominant epitope was identified in the N-terminal portion of BIV TM (Chen et al, 1994) and a TM peptide ELISA was developed from peptide mapping this region (Scobie et al, 1999).…”
Section: Introductionmentioning
confidence: 99%